| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.29B | 1.34B | 874.60M | 2.44B | 1.84B |
| Gross Profit | 254.07M | 315.03M | -33.79M | 1.09B | 931.47M |
| EBITDA | 367.29M | 545.61M | 225.60M | 1.33B | 1.21B |
| Net Income | 329.39M | 365.91M | 20.71M | 1.07B | 1.08B |
Balance Sheet | |||||
| Total Assets | 2.46B | 2.32B | 2.16B | 2.77B | 2.25B |
| Cash, Cash Equivalents and Short-Term Investments | 485.62M | 422.13M | 716.34M | 1.32B | 868.09M |
| Total Debt | 149.65M | 477.07M | 878.36M | 1.64B | 541.95M |
| Total Liabilities | 338.21M | 346.49M | 388.18M | 622.39M | 799.14M |
| Stockholders Equity | 2.12B | 1.97B | 1.77B | 2.15B | 1.45B |
Cash Flow | |||||
| Free Cash Flow | 319.32M | -62.79M | -267.51M | 1.14B | 691.45M |
| Operating Cash Flow | 520.28M | 480.66M | 129.00M | 1.37B | 1.17B |
| Investing Cash Flow | -200.97M | -517.25M | -169.99M | -175.88M | -471.28M |
| Financing Cash Flow | -255.07M | -256.93M | -562.87M | -744.77M | -1.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$84.78B | 7.76 | 48.55% | 9.80% | 11.50% | 17.54% | |
71 Outperform | HK$89.08B | 7.02 | 11.33% | 12.81% | -9.21% | -41.30% | |
69 Neutral | HK$13.65B | 5.38 | 18.24% | 10.40% | ― | ― | |
65 Neutral | HK$244.79B | 6.39 | 13.13% | 12.48% | -6.12% | -35.50% | |
63 Neutral | HK$15.44B | 26.23 | 2.51% | 2.88% | -19.46% | -55.11% | |
60 Neutral | HK$121.10B | 10.71 | 9.13% | 4.76% | 2.50% | -2.32% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% |